🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/04/1986 | 4,63 | 4,68 | 4,59 | 4,68 | +0,00% | 2,00% | 7.160.774 |
| 22/04/1986 | 4,78 | 4,78 | 4,64 | 4,68 | -2,22% | 2,91% | 8.734.032 |
| 21/04/1986 | 4,77 | 4,78 | 4,72 | 4,78 | +0,28% | 1,32% | 9.994.147 |
| 18/04/1986 | 4,74 | 4,85 | 4,74 | 4,77 | +0,42% | 2,37% | 18.735.725 |
| 17/04/1986 | 4,68 | 4,77 | 4,68 | 4,75 | +0,70% | 1,98% | 7.696.512 |
| 16/04/1986 | 4,63 | 4,74 | 4,63 | 4,72 | +2,74% | 2,58% | 10.284.653 |
| 15/04/1986 | 4,49 | 4,63 | 4,49 | 4,59 | +1,91% | 3,10% | 8.726.486 |
| 14/04/1986 | 4,41 | 4,51 | 4,40 | 4,51 | +2,33% | 2,40% | 9.360.317 |
| 11/04/1986 | 4,42 | 4,44 | 4,37 | 4,40 | +0,23% | 1,65% | 7.190.957 |
| 10/04/1986 | 4,37 | 4,39 | 4,29 | 4,39 | +1,38% | 2,27% | 11.876.774 |
| 09/04/1986 | 4,40 | 4,45 | 4,27 | 4,33 | -0,98% | 4,07% | 12.620.016 |
| 08/04/1986 | 4,37 | 4,40 | 4,31 | 4,38 | +0,99% | 2,05% | 10.077.149 |
| 07/04/1986 | 4,32 | 4,35 | 4,27 | 4,33 | -0,61% | 1,84% | 7.870.061 |
| 04/04/1986 | 4,48 | 4,52 | 4,32 | 4,36 | -3,52% | 4,44% | 8.171.885 |
| 03/04/1986 | 4,62 | 4,62 | 4,48 | 4,52 | -2,29% | 3,09% | 12.129.552 |
| 02/04/1986 | 4,65 | 4,65 | 4,56 | 4,63 | -0,78% | 1,86% | 10.118.650 |
| 01/04/1986 | 4,65 | 4,70 | 4,65 | 4,66 | +0,93% | 1,21% | 15.430.752 |
| 31/03/1986 | 4,53 | 4,64 | 4,51 | 4,62 | +2,65% | 2,85% | 10.062.058 |
| 27/03/1986 | 4,53 | 4,69 | 4,48 | 4,50 | +1,34% | 4,68% | 18.230.170 |
| 26/03/1986 | 4,31 | 4,44 | 4,31 | 4,44 | +3,96% | 3,08% | 8.560.483 |
| 25/03/1986 | 4,26 | 4,35 | 4,24 | 4,27 | +0,70% | 2,49% | 10.129.968 |
| 24/03/1986 | 4,28 | 4,29 | 4,21 | 4,24 | -0,77% | 1,86% | 6.934.406 |
| 21/03/1986 | 4,41 | 4,43 | 4,27 | 4,27 | -2,86% | 3,61% | 17.939.664 |
| 20/03/1986 | 4,32 | 4,45 | 4,32 | 4,40 | +2,95% | 3,15% | 9.703.642 |
| 19/03/1986 | 4,25 | 4,31 | 4,21 | 4,27 | +1,02% | 2,18% | 4.889.549 |
| 18/03/1986 | 4,21 | 4,28 | 4,19 | 4,23 | +0,08% | 2,12% | 7.813.469 |
| 17/03/1986 | 4,26 | 4,28 | 4,22 | 4,23 | -1,32% | 1,24% | 7.836.106 |
| 14/03/1986 | 4,15 | 4,29 | 4,12 | 4,28 | +4,27% | 4,23% | 14.604.509 |
| 13/03/1986 | 4,11 | 4,16 | 4,10 | 4,11 | -0,32% | 1,53% | 10.620.432 |
| 12/03/1986 | 4,09 | 4,18 | 4,09 | 4,12 | +1,30% | 2,35% | 10.428.019 |